Advanced search
Publication Cover
Current Medical Research and Opinion Volume 24, 2008 - Issue 8
Submit an article Journal homepage
169
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Tolerability of loteprednol/tobramycin versus dexamethasone/tobramycin in healthy volunteers: results of a 4-week, randomized, double-masked, parallel-group study

Jimmy D. Bartlett School of Optometry, University of Alabama at Birmingham, Birmingham, AL, USACorrespondence[email protected]
,
Edward J. Holland Cincinnati Eye Institute, Cincinnati, OH, USA
,
Dale W. Usner Bausch & Lomb, Inc., Rochester, NY, USA
,
Michael R. Paterno Bausch & Lomb, Inc., Rochester, NY, USA
&
Timothy L. Comstock Bausch & Lomb, Inc., Rochester, NY, USA
Pages 2219-2227 | Accepted 28 May 2008, Published online: 23 Jun 2008

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Timothy L Comstock & Edward J Holland. (2010) Loteprednol and tobramycin in combination: a review of their impact on current treatment regimens. Expert Opinion on Pharmacotherapy 11:5, pages 843-852.
Read now

Articles from other publishers (4)

Francis S. Mah & Paul M. Karpecki. (2021) Review of Loteprednol Etabonate 0.5%/Tobramycin 0.3% in the Treatment of Blepharokeratoconjunctivitis. Ophthalmology and Therapy 10:4, pages 859-875.
Crossref
Stephen C. Pflugfelder, Paul M. Karpecki & Victor L. Perez. (2014) Treatment of Blepharitis: Recent Clinical Trials. The Ocular Surface 12:4, pages 273-284.
Crossref
Timothy L. Comstock, Michael R. Paterno, Kirk M. Bateman, Heleen H. DeCory & Matthew Gearinger. (2012) Safety and Tolerability of Loteprednol Etabonate 0.5% and Tobramycin 0.3% Ophthalmic Suspension in Pediatric Subjects. Pediatric Drugs 14:2, pages 119-130.
Crossref
Timothy L. Comstock & Heleen H. DeCory. (2012) Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate. International Journal of Inflammation 2012, pages 1-11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.